Hangzhou Clongene Biotech Co., Ltd.

Hangzhou Clongene Biotech Co., Ltd. — FDA 510(k) Submissions

Hangzhou Clongene Biotech Co., Ltd. has submitted 9 FDA 510(k) premarket notifications since 2016, of which 9 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Test, Opiates, Over The Counter, Test, Amphetamine, Over The Counter, Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus, Enzyme Immunoassay, Cannabinoids, Enzyme Immunoassay, Amphetamine . Use the specialty filter in the sidebar to narrow results.